Amyotrophe Lateralsklerose: Neuer Wirkstoff RNS60 gibt Hoffnung

Article Properties
Refrences
Title Journal Journal Categories Citations Publication Date
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial

 European Journal of Neurology
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
 10 2023
Refrences Analysis
Refrences used by this article by year